SCHEMBL2553769

SCHEMBL2553769

CC(C)n1nnnc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7942980 0.81
Hydrochloric Acid SCHEMBL11540755 0.79 ALDH1A1 (0.32)
SCHEMBL11770562 0.78 HCAR3 (0.36)
SCHEMBL4812685 0.78 CYP1A2 (0.30)
SCHEMBL18827428 0.74
Hydrochloric Acid SCHEMBL10837729 0.74 ALDH1A1 (0.33)
SCHEMBL829122 0.74 ALDH1A1 (0.41)
SCHEMBL11401506 0.73 KDM4E (0.31)
SCHEMBL7541204 0.73
SCHEMBL4808569 0.72 ALDH1A1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6602655-B2 Stability; compatibility; mixture with antifogging agent EASTMAN KODAK COMPANY 2003-08-05 US claimed
US-20020168597-A1 Black-and-white developing compositions and methods of use CARESTREAM HEALTH, INC. 2002-11-14 US claimed
US-20020146652-A1 For use in processing silver halide materials, and particularly radiographic materials EASTMAN KODAK COMPANY 2002-10-10 US claimed
US-12016868-B2 Boronic acid derivatives and therapeutic uses thereof QPEX BIOPHARMA, INC. (US) 2024-06-25 US disclosed
US-11834663-B2 Fibrotic treatment MONASH UNIVERSITY (AU) 2023-12-05 US disclosed
US-11834663-B2 Fibrotic treatment MONASH UNIVERSITY (AU) 2023-12-05 US disclosed
US-20230357175-A1 RAR-ALPHA COMPOUNDS FOR INFLAMMATORY DISEASE AND MALE CONTRACEPTION Orphagen Pharmaceuticals, Inc. 2023-11-09 US disclosed
US-20230287009-A1 OXO-SUBSTITUTED COMPOUND Sumitomo Pharma Co., Ltd. (JP) 2023-09-14 US disclosed
US-20230287009-A1 OXO-SUBSTITUTED COMPOUND Sumitomo Pharma Co., Ltd. (JP) 2023-09-14 US disclosed
US-20230277571-A1 THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES MELINTA SUBSIDIARY CORP. 2023-09-07 US disclosed
US-20230277571-A1 THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES MELINTA SUBSIDIARY CORP. 2023-09-07 US disclosed
US-20020146652-A1 For use in processing silver halide materials, and particularly radiographic materials EASTMAN KODAK COMPANY 2002-10-10 US disclosed
EP-1227366-A1 Black-and-white developing compositions and methods of use EASTMAN KODAK COMPANY (US) 2002-07-31 EP disclosed
US-5955249-A HIGH BROMIDE TABULAR GRAIN EMULSION LAYER A 1-(P-ALKOXYPHENYL)-5-MERCAPTOTETRAZOLE TO INCREASE COVERING POWER. EASTMAN KODAK COMPANY (US) 1999-09-21 US disclosed
US-5876913-A Dual-coated radiographic elements with limited hydrophilic colloid coating coverages EASTMAN KODAK COMPANY (US) 1999-03-02 US disclosed
EP-0881536-A1 Dual-coated radiographic elements with limited hydrophilic colloid coating coverages EASTMAN KODAK COMPANY (US) 1998-12-02 EP disclosed
US-5800976-A BLUE TINTED FILM WITH SUPPORT, SILVER HALIDE EMULSION, GELATIN AND SENSITIZERS FOR SILVER COATING AND POWER ENHANCING COMPOUND EASTMAN KODAK COMPANY (US) 1998-09-01 US disclosed
US-5759759-A Radiographic elements exhibiting increased covering power and colder image tones EASTMAN KODAK COMPANY (US) 1998-06-02 US disclosed
US-3992377-A 3-Thio-substituted cephalosporin antibiotics ELI LILLY AND COMPANY (US) 1976-11-16 US disclosed
US-3962232-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1976-06-08 US disclosed